Trial
NCT02560038
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
—
Condition
Urinary Bladder Neoplasms
Intervention
Gemcitabine
Why stopped
slow enrollment; resource re-allocation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-28